Synonymous SNPs provide evidence for selective constraint on human exonic splicing enhancers

被引:60
作者
Carlini, DB [1 ]
Genut, JE [1 ]
机构
[1] American Univ, Dept Biol, Washington, DC 20016 USA
关键词
exonic splicing enhancers; single nucleotide polymorphisms; synonymous substitutions;
D O I
10.1007/s00239-005-0055-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human SNP database was used to detect selection on 238 hexamers previously identified as exonic splicing enhancers (ESEs). We compared the distribution of the 238 putative ESEs in biallelic and triallelic SNPs within five different functional categories of the SNP database: synonymous, nonsynonymous, introns, UTRs, and nongenic SNPs. Since true ESEs do not function outside of exons, SNPs that disrupt ESE motifs were expected to be more common in nonexonic portions of the genome. Our results supported this expectation: ESEs were least prevalent within synonymous SNPs and most common in nongenic SNPs. There were similar to 11% fewer ESEs within synonymous biallelic SNPs than expected under no selective constraint. We also compared the frequency of neutral SNPs, those where neither allele was an ESE, with deleterious SNPs, those where one or more alleles was an ESE, across the five different functional classes of SNPs. In comparison with the other functional classes of SNPs, synonymous SNPs contained an excess of neutral variants (+1.64% and +6.04% for biallelic and triallelic SNPs, respectively) and a dearth of deleterious variants (-13.11% and -52.39% for biallelic and triallelic SNPs, respectively). The observed patterns were consistent with purifying selection on the 238 hexamers to maintain their function as ESEs. However, in contrast to previous work, we did not find evidence for selection to maintain ESE function at nonsynonymous SNPs because selection at the protein level probably obscured any difference at the level of ESE function.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 36 条
[1]   How did alternative splicing evolve? [J].
Ast, G .
NATURE REVIEWS GENETICS, 2004, 5 (10) :773-782
[2]   EXON RECOGNITION IN VERTEBRATE SPLICING [J].
BERGET, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2411-2414
[3]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[4]   A 5′ splice site-proximal enhancer binds SF1 and activates exon bridging of a microexon [J].
Carlo, T ;
Sierra, R ;
Berget, SM .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) :3988-3995
[5]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[6]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[7]  
CHARLESWORTH B, 1993, GENETICS, V134, P1289
[8]   Finishing the euchromatic sequence of the human genome [J].
Collins, FS ;
Lander, ES ;
Rogers, J ;
Waterston, RH .
NATURE, 2004, 431 (7011) :931-945
[9]   The regulation of splice-site selection, and its role in human disease [J].
Cooper, TA ;
Mattox, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) :259-266
[10]   BRCA2 T2722R is a deleterious allele that causes exon skipping [J].
Fackenthal, JD ;
Cartegni, L ;
Krainer, AR ;
Olopade, OI .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (03) :625-631